179 related articles for article (PubMed ID: 19164486)
1. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.
Bassil AK; Bourdu S; Townson KA; Wheeldon A; Jarvie EM; Zebda N; Abuin A; Grau E; Livi GP; Punter L; Latcham J; Grimes AM; Hurp DP; Downham KM; Sanger GJ; Winchester WJ; Morrison AD; Moore GB
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G923-30. PubMed ID: 19164486
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of the P2Y14 receptor in human neutrophils.
Scrivens M; Dickenson JM
Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
[TBL] [Abstract][Full Text] [Related]
3. Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells.
Bar I; Guns PJ; Metallo J; Cammarata D; Wilkin F; Boeynams JM; Bult H; Robaye B
Mol Pharmacol; 2008 Sep; 74(3):777-84. PubMed ID: 18523137
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of the P2Y14 receptor in murine T-lymphocytes.
Scrivens M; Dickenson JM
Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide decreases gastric emptying and absorption.
Addisu A; Gower WR; Landon CS; Dietz JR
Exp Biol Med (Maywood); 2008 Apr; 233(4):475-82. PubMed ID: 18367637
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.
Scrivens M; Dickenson JM
Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433
[TBL] [Abstract][Full Text] [Related]
7. The UDP-glucose receptor P2RY14 triggers innate mucosal immunity in the female reproductive tract by inducing IL-8.
Arase T; Uchida H; Kajitani T; Ono M; Tamaki K; Oda H; Nishikawa S; Kagami M; Nagashima T; Masuda H; Asada H; Yoshimura Y; Maruyama T
J Immunol; 2009 Jun; 182(11):7074-84. PubMed ID: 19454705
[TBL] [Abstract][Full Text] [Related]
8. UDP-sugars activate P2Y
Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V
Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.
Hamel M; Henault M; Hyjazie H; Morin N; Bayly C; Skorey K; Therien AG; Mancini J; Brideau C; Kargman S
J Biomol Screen; 2011 Oct; 16(9):1098-105. PubMed ID: 21821827
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries.
Haanes KA; Edvinsson L
FEBS Lett; 2014 Aug; 588(17):2936-43. PubMed ID: 24911208
[TBL] [Abstract][Full Text] [Related]
11. Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.
Morrison K; Ernst R; Hess P; Studer R; Clozel M
J Pharmacol Exp Ther; 2010 Oct; 335(1):249-55. PubMed ID: 20660124
[TBL] [Abstract][Full Text] [Related]
12. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
Dovlatova N; Wijeyeratne YD; Fox SC; Manolopoulos P; Johnson AJ; White AE; Latif ML; Ralevic V; Heptinstall S
Thromb Haemost; 2008 Aug; 100(2):261-70. PubMed ID: 18690346
[TBL] [Abstract][Full Text] [Related]
13. Role of UDP-Sugar Receptor P2Y
Mikolajewicz N; Komarova SV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326617
[TBL] [Abstract][Full Text] [Related]
14. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents.
De Smet B; Thijs T; Peeters TL; Depoortere I
Neurogastroenterol Motil; 2007 Mar; 19(3):211-7. PubMed ID: 17300291
[TBL] [Abstract][Full Text] [Related]
15. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in gastrointestinal motility disturbances during acute necrotising pancreatitis.
Seerden TC; De Winter BY; Van Den Bossche RM; Herman AG; Pelckmans PA; De Man JG
Neurogastroenterol Motil; 2005 Oct; 17(5):671-9. PubMed ID: 16185305
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the A2A adenosine receptor reduces in-vitro prostate contractility in mature mice.
Gray KT; Short JL; Ledent C; Ventura S
Eur J Pharmacol; 2008 Sep; 592(1-3):151-7. PubMed ID: 18655781
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of alpha2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence.
Fülöp K; Zádori Z; Rónai AZ; Gyires K
Eur J Pharmacol; 2005 Dec; 528(1-3):150-7. PubMed ID: 16313902
[TBL] [Abstract][Full Text] [Related]
19. UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.
Gao ZG; Ding Y; Jacobson KA
Biochem Pharmacol; 2010 Mar; 79(6):873-9. PubMed ID: 19896471
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.
Lee SA; Park JH; Lee SY
Mol Cells; 2013 Sep; 36(3):273-7. PubMed ID: 24048691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
